• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    Shroom(rise) Kingdom

    Improving Taste and Mouthfeel of Plant-Based Protein Formulations
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    AHPA to Attend CITES Plants Committee Meeting in Geneva

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Shroom(rise) Kingdom
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study

    NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements

    Functional Beverage Market Shakes Things Up with Formulation Breakthroughs

    A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Verdure Sciences

    Gencor

    Xsto Solutions

    American FlexPack

    Botanic Healthcare LLC
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Verdure Sciences

    Gencor

    Xsto Solutions

    American FlexPack

    Botanic Healthcare LLC
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Pharmaceutical Manufacturing Equipment Trends

    Demand for flexibility remains the driving force behind equipment systems.

    Pharmaceutical Manufacturing Equipment Trends
    By Kristin Brooks, Managing Editor, Contract Pharma03.03.21
    As drug development trends change, so too must manufacturing processes and equipment. Contract Pharma looks into how the pandemic has impacted equipment needs, the latest technologies being leveraged in manufacturing, as well as continued challenges and where advances have been made across digital technologies, cell and gene manufacture, single use technologies, and continuous manufacturing.

    Pharma & Biopharma Trends   
    Personalized medicines topped one-third of all new drug approvals in 2020 for the third time in the last four years, according to a recent report from The Personalized Medicine Coalition. The U.S. FDA approved 19 personalized therapies, one cell-based immunotherapy, and eight new diagnostic indications, accounting for 39% of the new drugs FDA approved last year.1

    Key among the trends driving equipment needs is the growing number of complex and specialized therapies produced in small quantities, as well as drug delivery of therapies administered at home. In addition to flexibility for customization, is greater automation and modularity to address changing needs.

    Raffaele Pace, engineering vice president of operations for Stevanato Group, said, “The shift to more specialized therapies and the broader array of injection and inhaler devices, present significantly different designs in terms of size, material and shape, and require a complete change in manufacturing processes. Vendors are called to meet this requirement by offering flexible equipment that can process small batch sizes and handle different container types on a single machine, or assemble several formats or even different devices on the same line.” 

    Modularity is also key. Pace noted, whether an organization needs to scale up to increase production capacity or scale down to mix smaller batches, manufacturing equipment must adapt.

    Containment technologies play a big role in equipment needs for today’s specialized therapies. Dr. Andreas Mattern, director of product management pharma at Syntegon, said, “Biotechnologically produced drugs for the treatment of cancer, autoimmune diseases, or rare diseases affecting only a small patient population, are increasingly being developed and call for ever smaller batch sizes and highly flexible equipment. This trend is accompanied by the need for the highest product quality and protective measures. Containment technologies are highly requested, not only for liquid fill-finish lines, but also increasingly for oral solid dosage (OSD) forms. Here, containment equipment has the very important task of protecting operators from increasingly toxic substances.”

    Personalized medicines, such as those to treat orphan diseases, continue to have a massive impact on the pharmaceutical industry, according to Jan Deininger, group communications manager at OPTIMA Packaging Group. “Each drug represents a particularly high financial value and is complex to produce, which challenges the technology in various ways, most importantly safety and automation. This also influences the requirements for filling and closing machines. Small batches require high system flexibility as well as fully automated and fully safeguarded processes. Under these conditions and with these technologies, even small, very valuable batches can be processed very efficiently.”

    Optimization of equipment is also increasingly important for drug manufacturers. In the area of tablet press technology, Frederick Murray, president of KORSCH America Inc., said, “The emphasis on Overall Equipment Effectiveness continues to be a major consideration. Tracking machine uptime, output, and yields, in addition to key quality attributes, improvement efforts around reducing change times, or permitting a single operator to monitor multiple machines, are key focus areas.” Murray added that most products have been validated across a defined speed range of the tablet press, but often, there is the potential to run at the maximum validated speed if the right steps are taken with optimizing the press setup.

    Needs Amid The Pandemic
    The urgent need to produce millions of vaccines in short order has placed heavy demands on the industry. Here, manufacturing optimization is needed, leveraging production innovations and new technologies to accelerate processes with maximum efficiency.

    To address this Herculean task, according to Massimiliano Cesarini, sales director, Romaco S.r.l., “As a manufacturer of packaging and process technology, the main issue is the increased demand for high-performance technology for the aseptic filling of vaccines. To help address this need, Romaco’s Macofar VF high-speed machine fills vials with pharmaceutical liquids and biotech products under advanced aseptic conditions.” The machine has a maximum filling speed of 24,000 vials per hour and is able to maintain cold chains during filling, which is necessary for some vaccines and other pharmaceutical liquids.

    Due to the pandemic, the requirements for a filling line are even higher. “It’s not enough that it’s fast during operation, it must also enable production to start as quickly as possible. For this reason, many vaccine producers are moving away from isolator technology and opting for equipment with an open RABS (Restricted Access Barrier System),” Cesarini said.

    With respect to the Macofar VF, for example, equipped with open RABS, the machine is ready for production in about half the time and the validation and qualification of the system can be completed faster as well, according to Cesarini.

    More than 1,800 COVID-19 vaccines and therapies are currently being investigated in over 4,000 clinical trials, and according to Mattern of Syntegon, “Existing lab and manufacturing capacities must accordingly be reallocated or rebuilt in record time. For contract manufacturers, this need has resulted in an order increase of at least 200% in the infectious disease segment in 2020 compared to 2019.”   

    Many producers and developers of vaccines and active ingredients for the treatment of COVID-19 are using formulation systems, filling lines for vials, and inspection machines. According to Mattern, “Our experience with biologics enables us to support the production of novel mRNA vaccines with cold filling. Inspection machines from Syntegon are already used in the production process of mRNA COVID-19 vaccines.”

    The pharma industry is often slow in adopting production innovations or new technologies, but the COVID-19 pandemic has put pressure on accelerating these processes, according to Pace of Stevanato Group. “Vendors face an unprecedented challenge and are implementing strategies that enable them to operate even more efficiently, shifting in some cases from a traditional sequential process to an agile and modular approach. By ensuring equipment and software compatibility and consistency early on, the ramp-up process is expedited and the risk of unforeseen disruptive factors significantly reduced. Additionally, equipment should be future-proof, allowing a transition to other products, if necessary. For inspection, for instance, flexibility also means incorporating versatile technologies on automatic machines—capable of analyzing the full range of defect scenarios,” Pace said.

    With respect to processing and packaging equipment, Michele Leonardi, sales manager, Packaging Division for MG America, said, “Throughout 2020 and now in early 2021, we have noted a surge in the need for vial packaging equipment, mostly associated with COVID-19 vaccines. Speed has become increasingly paramount. The market saw urgent needs for equipment available in just a matter of weeks, when such machinery typically takes months to deliver, install and validate.”

    The industry is also moving toward greater automation, as there are a number of compelling reasons to do so. According to Deborah Smook, vice president of marketing & business development for TurboFil Packaging Machines LLC, “From a quality standpoint, there’s no question that automation leads to greater consistency. Even if throughput doesn’t increase, there is less waste with a more consistent process. Of course, with the pandemic there are additional incentives, including maintaining social distance between equipment operators.”

    Equipment Innovation
    Where the industry is slow to adopt change due to strict regulatory and validation requirements, increasingly lingering technology trends, such as digitalization and Artificial Intelligence (AI), are being leveraged for a high degree of flexibility in manufacturing processes, and greater efficiency. 

    The use of robots in liquid filling operations reduces the risk of contamination through human contact, according to Mattern of Syntegon. “Machine operators no longer need to perform repetitive tasks, which makes processes safer, more precise, reproducible and validatable. In the future, more and more robotic solutions will be used; the boundaries will continue to shift due to decreasing costs and new technologies such as AI,” Mattern said.

    “According to recent studies, next-generation digital technologies can help reduce pharma manufacturing costs by up to 20%, improve quality, and increase flexibility2; and pharma companies are likely to invest significantly in AI and Big Data over the next two years3,” said Pace of Stevanato Group. “In our operations, the prominent applications include AI and Digital Twin.”

    Pace explained, AI technology applied to automated visual inspection machines can help reduce parameterization and production costs, support robust root analysis and move to a predictive method exploiting the large amounts of data collected.

    Digital twin consists of a virtual replica of physical manufacturing equipment that can be used to run simulations before actual machines are built. Pace said, “This technology can offer a lot of data and visibility on how to optimize processes in the drug delivery device assembly.”

    The support of digitalization technologies for filling and closing processes is being further extended, according to Deininger of OPTIMA. “Optima has implemented a project in which video monitoring of the processing operations is almost comprehensive. In the event of an error message, this allows the cause to be narrowed down in detail, analyzed, and possibly large parts of batches to be saved, which would otherwise be rejected in their entirety,” said Deininger.

    Advances & Obstacles
    While there have been significant advances in manufacturing innovation, certain challenges remain in the burgeoning area of Advanced Therapy Medicinal Products (ATMPs), based on genes, tissues or cells. Also, while Single Use Technologies (SUTs) are fast becoming the gold standard, and continuous production strategies make headway in OSD, certain obstacles remain.

    With a growing number of approved therapies offering impressive outcomes, cell therapies hold great promise, however, commercial manufacturing of these complex and costly therapies is a key challenge. Dr. Tania Pereira Chilima, deputy CTO at Univercells Technologies, said, “Cell and gene therapies continue to be challenging to develop processes that can scale-up through to commercial manufacturing because the technologies that exist are not purpose fit for the special needs of these advanced therapies. And while innovation is happening, companies are also looking to control the cost of goods sold (COGs) to reliably produce and deliver commercial volumes of drugs to the market. This requires technologies that are readily available and validated for use.”

    The costs for this form of therapy are still extremely high today and the production process is complex, noted Deininger of OPTIMA. “Pharmaceutical engineering is challenged to contribute solutions for efficient, cost-effective production and filling by further automating and optimally safeguarding the manufacturing and processing steps. Platforms specifically for cell and gene therapies are needed,” Deininger said. To that end, OPTIMA designed automated, modular and highly flexible machine platforms based on isolator technology that can be equipped with robotic functions.

    With respect to Single Use Technologies, Chilima said, “SUTs are increasingly being used across the industry because the flexibility they offer is a real advantage over stainless-steel. Though it was met with skepticism at first, SUTs have left the state of nascent technology to become a standard reference.” However, challenges to implementation can still be associated with these technologies—most notably their sourcing and supply chain, according to Chilima, noting lead times can be long, especially during the current pandemic.

    Lastly, in the field of continuous tablet production, significant technical advancements have been made, including in-line granulation, blending, compression, and coating, according to Murray of KORSCH America Inc. “The increased use of Process Analytical Technology (PAT) sensors and fully integrated control systems has increased the capability of these systems, however, validation execution and capital investment remain the key barriers,” said Murray. “The tablet press is a critical component in any continuous production line; however, the press control system must be fully integrated with the central line system to permit control of peripherals, override capability on the material feed and tablet discharge, and full integration of process parameters, including in-line NIR probes,” added Murray.

    As more and more linked and chained processes are being developed, the main challenge is automating the processes by connecting technologies from different suppliers to develop fully integrated processes, according to Chilima of Univercells Technologies. “In addition to this technical challenge, the integration of continuous quality control (QC) testing solutions remains a key point from a regulatory perspective for the industry,” said Chilima.

    While continuous manufacturing is an unbroken trend in OSD production, Syntegon has developed a different approach. Mattern explained, “As opposed to the common complex mass flow rate based approach, excipients and active ingredients are dosed as a discrete mass on both the Xelum production platform and the Xelum R&D unit. This makes it possible to dose even smallest amounts of APIs of less than 1% reliably.”

    According to Pace of Stevanato Group, this pandemic offered a vital lesson for the future: optimizing the engineering and manufacturing equipment process, integrating proof-of-value stages through tight cooperation with customers, and use of new technologies is possible. 


    Kristin Brooks is the Managing Editor of Contract Pharma. She can reached at KBrooks@RodmanMedia.com

    References
    1. Personalized Medicine Coalition, Personalized Medicine at FDA: The Scope & Significance of Progress in 2020, www.personalizedmedicinecoalition.org
    2. Bain & Company, Digital Manufacturing Is (Finally) Coming to Pharma, 2020
    3. GlobalData, Digital Transformation and Emerging Technology in the Healthcare Industry, 2020 Edition
    Related Searches
    • Contract Manufacturing
    • Medical Nutrition
    Related Knowledge Center
    • Medical Nutrition
    • Contract Manufacturing
    Suggested For You
    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    MartinBauer Launches Line of Floral Ingredients for Beverages MartinBauer Launches Line of Floral Ingredients for Beverages
    CRN Petitions FDA to Change Course on CRN Petitions FDA to Change Course on 'Drug Preclusion'
    Trends in the Nutraceuticals Market Trends in the Nutraceuticals Market
    Tocotrienol Linked to Post-Radiation GI Recovery in Animal Study Tocotrienol Linked to Post-Radiation GI Recovery in Animal Study
    New Categories Where Berry Ingredients Can Shine New Categories Where Berry Ingredients Can Shine
    Cellular Aging and Longevity: Ingredients for a New Age of Health Cellular Aging and Longevity: Ingredients for a New Age of Health
    Kyowa Hakko’s Setria Glutathione Approved as Health Ingredient In Brazil Kyowa Hakko’s Setria Glutathione Approved as Health Ingredient In Brazil
    Cerebiome Probiotic Blend Linked to Potential Anxiety Benefits in SHIME Model Cerebiome Probiotic Blend Linked to Potential Anxiety Benefits in SHIME Model
    KHSA Approves Use of IFOS Logo on Korean Manufactured Omega-3s KHSA Approves Use of IFOS Logo on Korean Manufactured Omega-3s
    Nutriventia Receives Clean Label Project Certification for Two Branded Ingredients Nutriventia Receives Clean Label Project Certification for Two Branded Ingredients
    Academy of Nutrition and Dietetics Names New CEO Academy of Nutrition and Dietetics Names New CEO
    Study: Prenatal Supplements Not Meeting Target Dosages Study: Prenatal Supplements Not Meeting Target Dosages
    Women In Nutraceuticals (WIN) Partners on ‘Formulating for Women’ Panel at SupplySide East Women In Nutraceuticals (WIN) Partners on ‘Formulating for Women’ Panel at SupplySide East
    CBD and Pet Health: Wellness for Our Four-Legged Friends CBD and Pet Health: Wellness for Our Four-Legged Friends

    Related Features

    • Dietary Supplements | Healthcare Trends | Research | Sports Nutrition | Weight Management/Weight Loss
      Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders

      Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders

      Studies attempting to link supplements to ED are inadequately designed, and often conflate drugs and dietary supplements.
      By Mike Montemarano, Associate Editor 05.23.23

    • Breaking News | Flavors & Colors | Functional Foods & Beverages | Herbs & Botanicals | Supplier News
      MartinBauer Launches Line of Floral Ingredients for Beverages

      MartinBauer Launches Line of Floral Ingredients for Beverages

      The variety of ingredient forms ensures that flavors and fragrances can be suitable for any beverage format.
      05.19.23

    • Breaking News | Dietary Supplements | Industry & Market News | Regulations | Regulatory News
      CRN Petitions FDA to Change Course on

      CRN Petitions FDA to Change Course on 'Drug Preclusion'

      CRN asked for clearer and more consistent application of the statute which prohibits ingredients from dietary supplements due to past drug research.
      By Mike Montemarano, Associate Editor 05.10.23


    • Trends in the Nutraceuticals Market

      Trends in the Nutraceuticals Market

      Lauren Samot, Head of Commercial Innovation and Product Development at Vitaquest International, shares insights nutraceutical industry trends.

    • Antioxidants | Breaking News | Research News | Vitamins
      Tocotrienol Linked to Post-Radiation GI Recovery in Animal Study

      Tocotrienol Linked to Post-Radiation GI Recovery in Animal Study

      The animal model of radiation therapy linked Gamma tocotrienols to a reduction in cell damage.
      05.02.23

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    Breaking News
    • SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    • Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    • AHPA to Attend CITES Plants Committee Meeting in Geneva
    • NY General Assembly Passes Bill to Restrict Sales of Weight Loss Supplements
    • Stefan Pasiakos, PhD, Selected to Lead NIH Office of Dietary Supplements
    View Breaking News >
    CURRENT ISSUE

    June 2023

    • Functional Beverage Market Shakes Things Up with Formulation Breakthroughs
    • A Kingdom of Their Own: Fungi Shine While Mushrooms Emerge as Market Stars
    • The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion
    • (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands
    • Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    • KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    SmartyPants Vitamins Launches New Line of Gelatin-Free Multivitamin Gummies
    Flavanol Deficiency Linked to Age-Related Memory Decline: COSMOS-Web Study
    AHPA to Attend CITES Plants Committee Meeting in Geneva
    Coatings World

    Latest Breaking News From Coatings World

    PPG Opens $30-Million Battery Pack Application Center in China
    Fact.MR: Steel Pipe Coatings Market To Hit $14.0 Billion By 2033
    Omya Extends Lightweight Fillers Portfolio with the Acquisition of Bublon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Microbot receives Grant for Endovascular Surgical Robot System
    Recall of Abiomed's Impella 5.5 with SmartAssist is Class I
    New FDA Nod Boosts Philips, Masimo Partnership
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KBI Biopharma Unveils KBI PUREplatform
    AGC Biologics Introduces AGCellerate to Deliver IND-Ready GMP Material
    Element Creates New Lab Solutions Division
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fasten Wins Gold at German Innovation Awards
    Attitude Expands Oceanly Makeup Collection
    L'Oréal Leads Funding Round for Biotech Company, Debut
    Happi

    Latest Breaking News From Happi

    Skylar’s ‘Boardwalk Delight’ Eau de Parfum Launches to Record Success at Sephora
    Register for the IBA Cocktail Reception in Las Vegas During Cosmoprof North America
    Amyris Announces Transformation Program
    Ink World

    Latest Breaking News From Ink World

    DuPont Artistri Inks Expands Pigment Inks Portfolio at ITMA 2023
    Toyochem Constructs New Pilot Facility for High-Performance Polymers
    UFlex Reports Unaudited 4Q, Full Year 2023 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Baldwin to exhibit 'Complete Quality Control Solutions' at High Security Printing Latin America
    Label Source acquires division of OMNI Systems
    Vetaphone demos ‘M’ corona treater at Mark Andy showroom
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Maxcess International Opens New Facility in Mumbai
    emtec Showcases Groundbreaking Achievement in Haptic Measurement
    Hollingworth & Vose Joins United Nations Global Compact initiative
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthonika Receives Grant for Total Meniscus Replacement
    Treace to Buy RPM-3D Tech for Up to $30 Million
    Former BD, J&J Executives Join Acuitive Technologies Board
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Schreiner Group Receives Three FINAT Awards
    MClimate Releases Maintenance-Free CO2 Display
    Blackstone Completes Acquisition of Majority Stake of Copeland

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login